Use of Antifibrinolytics in Pediatric Life-Threatening Hemor... : Critical Care Medicine

1Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA.

2Division of Emergency Medicine, Department of Pediatrics, The Ohio State University College of Medicine, Nationwide Children’s Hospital, Columbus, OH.

3Division of Pediatric Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Children’s Hospital of Pittsburgh, Pittsburgh, PA.

4Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA.

Use of Antifibrinolytics in Pediatric Life-Threatening Hemor... : Critical Care Medicine

5Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA.

6Department of Surgery, University of Pittsburgh School of Medicine, Children’s Hospital of Pittsburgh, Pittsburgh, PA.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).

Dr. Spinella is a consultant for Secure Transfusion Services, Hemanext, and Haima; Dr. Leonard receives royalty payments from UpToDate; Dr. Josephson is a consultant for Immucor, Octapharma, and Cellphine, and has an unrestricted grant from Medtronics. Drs. Spinella, Leonard, and Josephson received support for article research from the National Institutes of Health. Dr. Leonard’s institution received funding from National Institutes of Child Health and Development. The remaining authors have disclosed that they do not have any potential conflicts of interest.

The original MAssive Transfusion epidemiology and outcomes In Children study was supported, in part, by grant R21HL128863 from the National Heart, Lung and Blood Institute. No direct funding was received for the present study.

MAssive Transfusion epidemiology and outcomes In Children (MATIC) Investigators are listed in Appendix 1.

For information regarding this article, E-mail: [email protected]

Tags: